Key pipeline advancements to propel myelodysplastic syndromes market to $2.4 bn by 2028: GlobalData Read more
Industry recommends changes in draft guidelines for discontinuation of scheduled formulations Read more
DKSH to commercialise seven generic formulations of Biocon Pharma in Singapore and Thailand Read more